New to Neuro

CTN and CTX schemes smooth the way for clinical trials in Australia

This blog will explore the role/ definition and introduction of the CTN and CTX schemes and how these scheme are shaping the clinical trials sector in Australia  With clinical trials activity growing globally the pressure is on clinical trials providers to streamline their services. Clinical trials are a growth sector worldwide driven by our desire MORE


NTA at STROKE 2017 – Queenstown

Are you attending STROKE 2017 in Queenstown? Drop in and say hello to NTA at stand 4. The 27th Annual Scientific Meeting of the Stroke Society of Australasia will be held from 23 to 25 August 2017 in beautiful Queenstown, New Zealand. The conference theme “Path to Recovery” signals the commitment to achieving excellence in MORE



Neuroscience clinical trials, Melbourne and why we lead the way

Australia has a long standing position as an global leader in the clinical trial space. There is a plethora of reasons making Australia a desirable destination for clinical trials. The R&D tax incentives scheme is available to foreign stakeholders, the regulatory environment is advantageous with no IND required, a universal healthcare system that supports clinical MORE


NTA to attend European Neuro Convention – London

NTA is excited to be an exhibitor at the upcoming European Neuro Convention in London on the 7th & 8th June. We’d love for you to pop over to booth 6010 and introduce yourself if you are attending the event. The event for professionals, researchers, clinicians, surgeons and their teams working in the neuro field. MORE


Breakthrough in motor neurone disease research gives hope.

Breakthrough in motor neurone disease research gives hope. Copper could hold the key to a radical new treatment to help those affected by this indiscriminate and fatal disease To read the full article, please click on the link below. NTA is proud to be the CRO involved with this exciting project in ALS/MND research. https://pursuit.unimelb.edu.au/articles/breakthrough-in-motor-neurone-disease-research-gives-hope


Upcoming Neurotech Investing and Partnering Conference

NTA wil be travelling to sunny San Francisco to attend the Neurotech Investing and Partnering Conference from the 31st May to 1st June 2017. The conference is a global forum where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to MORE


2017 NANS Annual Meeting

NTA staff travelled to Las Vegas in January to attend the NANS 20th Annual Meeting. The theme  was Neuromodulation: From Frontier to Frontline. It was a fantastic event allowing us to make lots of new connections and further promote the capabilities of NTA.  


NTA at DIA 2016

From June 26 – 30 NTA attended DIA 2016 in Philadelphia. DIA is the largest global interdisciplinary event that brings together key thought leaders and innovators from industry, academia, regulatory and government agencies, health, patient, and philanthropic organizations from around the globe.    


Trial of the Year award

On the 20th May, the Australian Clinical Trials Alliance celebrated international Clinical trials Day, in partnership with Medicines Australia, AusBiotech and Research Australia, with a breakfast and “Trial of the Year” awards, celebrating Australian leadership and excellence in clinical trials. The ACTA Trial of the Year Award is a new initiative established as a way MORE